A review on coronary artery disease, its risk factors, and therapeutics

• Published in: Journal of cellular physiology Vol. 234; no. 10; pp. 16812 - 16823
• Main Authors: Malakar, Arup Kr, Choudhury, Debashree, Halder, Binata, Paul, Prosenjit, Uddin, Arif, Chakraborty, Supriyo
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.10.2019
• Subjects: Angina; Antagonists; Calcium antagonists; Cardiovascular disease; Cardiovascular diseases; Chemical compounds; Chromosome 9; Chromosomes; Coronary artery; Coronary artery disease; Coronary Artery Disease - diagnosis; Coronary Artery Disease - epidemiology; Coronary Artery Disease - genetics; Coronary Artery Disease - pathology; Coronary vessels; Developing countries; Diabetes mellitus; Environmental factors; Genetic factors; Genetic Predisposition to Disease; Genome-wide association studies; Genomes; Health risk assessment; Heart diseases; Homocystinuria; Human populations; Humans; Hyperlipidemia; Hypertension; LDCs; low‐density lipoproteins; Nitrates; Pharmacology; Psychological stress; Risk analysis; Risk Factors; Smoking; Social interactions; coronary artery disease; cardiovascular disease; low-density lipoproteins
• ISSN: 0021-9541; 1097-4652; 1097-4652
• DOI: 10.1002/jcp.28350

Coronary artery disease (CAD) is one of the major cardiovascular diseases affecting the global human population. This disease has been proved to be the major cause of death in both the developed and developing countries. Lifestyle, environmental factors, and genetic factors pose as risk factors for the development of cardiovascular disease. The prevalence of risk factors among healthy individuals elucidates the probable occurrence of CAD in near future. Genome‐wide association studies have suggested the association of chromosome 9p21.3 in the premature onset of CAD. The risk factors of CAD include diabetes mellitus, hypertension, smoking, hyperlipidemia, obesity, homocystinuria, and psychosocial stress. The eradication and management of CAD has been established through extensive studies and trials. Antiplatelet agents, nitrates, β‐blockers, calcium antagonists, and ranolazine are some of the few therapeutic agents used for the relief of symptomatic angina associated with CAD. Coronary artery disease (CAD) is one of the major cardiovascular diseases affecting the global human population. This disease has been proved to be the major cause of death in both the developed and developing countries. Lifestyle, environmental factors, and genetic factors pose as risk factors for the development of cardiovascular disease. The prevalence of risk factors among healthy individuals elucidates the probable occurrence of CAD in near future. Genome‐wide association studies have suggested the association of chromosome 9p21.3 in the premature onset of CAD. The risk factors of CAD include diabetes mellitus, hypertension, smoking, hyperlipidemia, obesity, homocystinuria, and psychosocial stress. The eradication and management of CAD has been established through extensive studies and trials. Antiplatelet agents, nitrates, β‐blockers, calcium antagonists, and ranolazine are some of the few therapeutic agents used for the relief of symptomatic angina associated with CAD.